SIMILAR PATTERNS OF AMINO ACIDS FOR 4N09_D_ADND401

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1b0k PROTEIN (ACONITASE)

(Sus scrofa)
PF00330
(Aconitase)
PF00694
(Aconitase_C)
5 ASP A 454
GLY A 451
ALA A 461
PHE A 326
GLY A 436
None
0.96A 4n09D-1b0kA:
undetectable
4n09D-1b0kA:
19.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1dgm ADENOSINE KINASE

(Toxoplasma
gondii)
PF00294
(PfkB)
7 ASN A  20
ASP A  24
GLY A  68
GLY A  69
ASN A  73
GLY A 315
ASP A 318
ADN  A 375 ( 3.8A)
ADN  A 375 (-2.9A)
ADN  A 375 ( 4.5A)
ADN  A 375 (-2.9A)
ADN  A 375 ( 4.9A)
ACY  A 370 (-3.1A)
ADN  A 375 ( 3.1A)
0.48A 4n09D-1dgmA:
41.5
4n09D-1dgmA:
34.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1dgm ADENOSINE KINASE

(Toxoplasma
gondii)
PF00294
(PfkB)
8 ASP A  24
LEU A  46
GLY A  68
GLY A  69
ASN A  73
CYH A 127
GLY A 315
ASP A 318
ADN  A 375 (-2.9A)
None
ADN  A 375 ( 4.5A)
ADN  A 375 (-2.9A)
ADN  A 375 ( 4.9A)
ADN  A 375 ( 4.2A)
ACY  A 370 (-3.1A)
ADN  A 375 ( 3.1A)
0.61A 4n09D-1dgmA:
41.5
4n09D-1dgmA:
34.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1geu GLUTATHIONE
REDUCTASE


(Escherichia
coli)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
6 LEU A 334
GLY A  16
GLY A  15
ALA A 317
ASN A 304
GLY A 140
None
None
FAD  A 451 (-3.5A)
None
None
FAD  A 451 (-3.5A)
1.02A 4n09D-1geuA:
4.9
4n09D-1geuA:
22.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rk2 RIBOKINASE

(Escherichia
coli)
PF00294
(PfkB)
5 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
0.35A 4n09D-1rk2A:
33.3
4n09D-1rk2A:
26.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tz6 PUTATIVE SUGAR
KINASE


(Salmonella
enterica)
PF00294
(PfkB)
6 ASP A  16
GLY A  30
GLY A  31
ASN A  35
GLY A 249
ASP A 252
AIS  A 402 (-2.5A)
AIS  A 402 ( 4.2A)
AIS  A 402 (-3.8A)
AIS  A 402 (-3.9A)
AIS  A 402 ( 4.5A)
AIS  A 402 (-3.0A)
0.54A 4n09D-1tz6A:
30.5
4n09D-1tz6A:
24.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v19 2-KETO-3-DEOXYGLUCON
ATE KINASE


(Thermus
thermophilus)
PF00294
(PfkB)
6 LEU A 170
GLY A  33
GLY A  34
ASN A  38
GLY A 248
ASP A 251
None
1.01A 4n09D-1v19A:
30.6
4n09D-1v19A:
28.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vef ACETYLORNITHINE/ACET
YL-LYSINE
AMINOTRANSFERASE


(Thermus
thermophilus)
PF00202
(Aminotran_3)
5 GLY A 257
GLY A 294
ALA A  69
ASN A 287
GLY A 286
None
0.95A 4n09D-1vefA:
3.2
4n09D-1vefA:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vgp 373AA LONG
HYPOTHETICAL CITRATE
SYNTHASE


(Sulfurisphaera
tokodaii)
PF00285
(Citrate_synt)
5 LEU A  27
GLY A 216
GLY A 217
ASN A 219
GLY A 251
None
0.91A 4n09D-1vgpA:
undetectable
4n09D-1vgpA:
23.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vm7 RIBOKINASE

(Thermotoga
maritima)
PF00294
(PfkB)
5 ASP A  14
GLY A  39
GLY A  40
ASN A  44
ASP A 246
None
0.57A 4n09D-1vm7A:
31.8
4n09D-1vm7A:
26.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2abq FRUCTOSE 1-PHOSPHATE
KINASE


(Bacillus
halodurans)
PF00294
(PfkB)
7 ASN A   8
ASP A  12
GLY A  36
GLY A  37
ASN A  41
GLY A 246
ASP A 249
None
1.17A 4n09D-2abqA:
26.5
4n09D-2abqA:
24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2afb 2-KETO-3-DEOXYGLUCON
ATE KINASE


(Thermotoga
maritima)
PF00294
(PfkB)
6 LEU A 171
GLY A  32
GLY A  33
ASN A  37
GLY A 277
ASP A 280
None
1.07A 4n09D-2afbA:
30.6
4n09D-2afbA:
23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ajr SUGAR KINASE, PFKB
FAMILY


(Thermotoga
maritima)
PF00294
(PfkB)
7 ASN A   8
ASP A  12
GLY A  39
GLY A  40
ASN A  44
GLY A 258
ASP A 261
None
ACT  A 321 (-3.1A)
ACT  A 321 ( 4.3A)
ACT  A 321 (-3.9A)
ACT  A 321 (-3.9A)
None
None
1.04A 4n09D-2ajrA:
25.5
4n09D-2ajrA:
25.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2c49 SUGAR KINASE MJ0406

(Methanocaldococcus
jannaschii)
PF00294
(PfkB)
6 ASP A  17
GLY A  42
GLY A  43
ASN A  47
GLY A 244
ASP A 247
ADN  A1301 (-2.8A)
ADN  A1301 (-3.4A)
ADN  A1301 (-3.3A)
ADN  A1301 (-3.4A)
None
ADN  A1301 (-2.9A)
0.77A 4n09D-2c49A:
29.5
4n09D-2c49A:
25.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2f02 TAGATOSE-6-PHOSPHATE
KINASE


(Enterococcus
faecalis)
PF00294
(PfkB)
7 ASN A   8
ASP A  12
GLY A  36
GLY A  37
ASN A  41
GLY A 252
ASP A 255
None
None
None
None
None
ATP  A 411 (-3.6A)
ATP  A 411 (-4.1A)
1.07A 4n09D-2f02A:
26.2
4n09D-2f02A:
25.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2i6b ADENOSINE KINASE

(Homo sapiens)
PF00294
(PfkB)
8 ASN A  14
ASP A  18
GLY A  63
GLY A  64
ASN A  68
CYH A 123
GLY A 297
ASP A 300
89I  A 500 (-4.0A)
None
None
89I  A 500 (-3.5A)
None
None
None
None
0.67A 4n09D-2i6bA:
42.8
4n09D-2i6bA:
40.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2i6b ADENOSINE KINASE

(Homo sapiens)
PF00294
(PfkB)
7 ASN A  14
GLY A  63
GLY A  64
ASN A  68
PHE A 170
GLY A 297
ASP A 300
89I  A 500 (-4.0A)
None
89I  A 500 (-3.5A)
None
89I  A 500 (-3.8A)
None
None
0.54A 4n09D-2i6bA:
42.8
4n09D-2i6bA:
40.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2i6b ADENOSINE KINASE

(Homo sapiens)
PF00294
(PfkB)
9 ASP A  18
LEU A  40
GLY A  63
GLY A  64
ASN A  68
CYH A 123
ALA A 136
GLY A 297
ASP A 300
None
89I  A 500 ( 4.8A)
None
89I  A 500 (-3.5A)
None
None
89I  A 500 (-3.4A)
None
None
0.67A 4n09D-2i6bA:
42.8
4n09D-2i6bA:
40.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2i6b ADENOSINE KINASE

(Homo sapiens)
PF00294
(PfkB)
6 LEU A  40
GLY A  64
ASN A  68
CYH A 123
ALA A 136
GLY A 297
89I  A 500 ( 4.8A)
89I  A 500 (-3.5A)
None
None
89I  A 500 (-3.4A)
None
1.33A 4n09D-2i6bA:
42.8
4n09D-2i6bA:
40.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2i6x HYDROLASE, HALOACID
DEHALOGENASE-LIKE
FAMILY


(Porphyromonas
gingivalis)
PF13419
(HAD_2)
5 ASP A 172
LEU A  37
GLY A  11
GLY A  10
ASN A 176
None
0.85A 4n09D-2i6xA:
4.1
4n09D-2i6xA:
22.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ibu ACETYL-COA
ACETYLTRANSFERASE


(Homo sapiens)
PF00108
(Thiolase_N)
PF02803
(Thiolase_C)
5 ASN A 158
LEU A  67
GLY A  97
ALA A  64
GLY A 183
None
1.00A 4n09D-2ibuA:
undetectable
4n09D-2ibuA:
23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ify 2,3-BISPHOSPHOGLYCER
ATE-INDEPENDENT
PHOSPHOGLYCERATE
MUTASE


(Bacillus
anthracis)
PF01676
(Metalloenzyme)
PF06415
(iPGM_N)
5 ASP A 402
GLY A  12
GLY A 445
ALA A 460
GLY A  64
MN  A 601 (-2.4A)
None
None
None
None
0.84A 4n09D-2ifyA:
5.0
4n09D-2ifyA:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jg5 FRUCTOSE 1-PHOSPHATE
KINASE


(Staphylococcus
aureus)
PF00294
(PfkB)
7 ASN A   8
ASP A  12
GLY A  36
GLY A  37
ASN A  41
GLY A 246
ASP A 249
None
1.19A 4n09D-2jg5A:
25.9
4n09D-2jg5A:
24.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jgv TAGATOSE-6-PHOSPHATE
KINASE


(Staphylococcus
aureus)
PF00294
(PfkB)
5 ASP A  12
GLY A  36
GLY A  37
ASN A  41
ASP A 254
None
0.86A 4n09D-2jgvA:
25.7
4n09D-2jgvA:
22.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jgv TAGATOSE-6-PHOSPHATE
KINASE


(Staphylococcus
aureus)
PF00294
(PfkB)
5 ASP A  12
GLY A  36
GLY A  37
ASN A  41
CYH A  90
None
0.99A 4n09D-2jgvA:
25.7
4n09D-2jgvA:
22.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jgv TAGATOSE-6-PHOSPHATE
KINASE


(Staphylococcus
aureus)
PF00294
(PfkB)
5 GLY A  36
GLY A  37
ASN A  41
GLY A 251
ASP A 254
None
0.71A 4n09D-2jgvA:
25.7
4n09D-2jgvA:
22.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2nwh CARBOHYDRATE KINASE

(Agrobacterium
fabrum)
PF00294
(PfkB)
5 ASP A  13
GLY A  37
GLY A  38
ASN A  42
ASP A 253
None
None
CL  A 403 (-3.5A)
None
None
0.97A 4n09D-2nwhA:
26.3
4n09D-2nwhA:
27.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qcv PUTATIVE
5-DEHYDRO-2-DEOXYGLU
CONOKINASE


(Bacillus
halodurans)
PF00294
(PfkB)
6 ASP A  22
GLY A  43
GLY A  44
ASN A  48
GLY A 269
ASP A 272
None
None
None
None
None
PGE  A 332 (-3.6A)
0.56A 4n09D-2qcvA:
30.9
4n09D-2qcvA:
24.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vaw CELL DIVISION
PROTEIN FTSZ


(Pseudomonas
aeruginosa)
PF00091
(Tubulin)
PF12327
(FtsZ_C)
5 LEU A  83
GLY A  20
GLY A 110
ALA A  82
GLY A  72
None
GDP  A1317 (-3.4A)
GDP  A1317 (-3.2A)
None
None
0.96A 4n09D-2vawA:
8.6
4n09D-2vawA:
23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z8z LIPASE

(Pseudomonas sp.
MIS38)
PF00353
(HemolysinCabind)
5 ASN A 441
GLY A 403
ASN A 405
GLY A 382
ASP A 400
None
CA  A 621 ( 4.7A)
CA  A 621 (-2.8A)
CA  A 621 ( 4.8A)
CA  A 621 (-2.3A)
0.96A 4n09D-2z8zA:
undetectable
4n09D-2z8zA:
20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a8u OMEGA-AMINO
ACID--PYRUVATE
AMINOTRANSFERASE


(Pseudomonas
putida)
PF00202
(Aminotran_3)
5 LEU X 186
GLY X 416
GLY X 417
ASN X 168
GLY X 167
None
0.99A 4n09D-3a8uX:
undetectable
4n09D-3a8uX:
25.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3czm L-LACTATE
DEHYDROGENASE


(Toxoplasma
gondii)
PF00056
(Ldh_1_N)
PF02866
(Ldh_1_C)
5 ASP A 143
GLY A 288
GLY A 193
ASN A 165
ASP A 168
None
0.99A 4n09D-3czmA:
5.9
4n09D-3czmA:
20.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ewm UNCHARACTERIZED
SUGAR KINASE PH1459


(Pyrococcus
horikoshii)
PF00294
(PfkB)
7 ASP A  13
LEU A 167
GLY A  33
GLY A  34
ASN A  38
GLY A 244
ASP A 247
None
1.05A 4n09D-3ewmA:
29.7
4n09D-3ewmA:
23.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3go7 RIBOKINASE RBSK

(Mycobacterium
tuberculosis)
PF00294
(PfkB)
6 ASP A  25
GLY A  50
GLY A  51
ASN A  55
GLY A 239
ASP A 242
RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
0.54A 4n09D-3go7A:
28.7
4n09D-3go7A:
27.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hj6 FRUCTOKINASE

(Halothermothrix
orenii)
PF00294
(PfkB)
6 ASP A  33
LEU A 188
GLY A  54
GLY A  55
ASN A  59
ASP A 275
None
0.80A 4n09D-3hj6A:
28.3
4n09D-3hj6A:
24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i3y CARBOHYDRATE KINASE

(Klebsiella
pneumoniae)
PF00294
(PfkB)
6 ASP A  12
GLY A  37
GLY A  38
ASN A  42
GLY A 229
ASP A 232
None
0.84A 4n09D-3i3yA:
26.1
4n09D-3i3yA:
23.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3in1 UNCHARACTERIZED
SUGAR KINASE YDJH


(Escherichia
coli)
PF00294
(PfkB)
6 ASP A  15
GLY A  41
GLY A  42
ASN A  46
GLY A 257
ASP A 260
None
None
None
None
NA  A 411 ( 4.9A)
None
0.73A 4n09D-3in1A:
31.1
4n09D-3in1A:
26.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ive NUCLEOTIDASE

(Escherichia
coli)
PF00149
(Metallophos)
PF02872
(5_nucleotid_C)
5 GLY A 373
GLY A 372
ASN A 370
GLY A 471
ASP A 472
CTN  A 603 (-3.3A)
CTN  A 603 (-3.2A)
CTN  A 603 (-3.2A)
None
CTN  A 603 (-2.7A)
0.98A 4n09D-3iveA:
undetectable
4n09D-3iveA:
21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jty BENF-LIKE PORIN

(Pseudomonas
protegens)
PF03573
(OprD)
5 GLY A 312
GLY A 311
ALA A 321
GLY A 153
ASP A 151
None
0.96A 4n09D-3jtyA:
undetectable
4n09D-3jtyA:
22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kfu GLUTAMYL-TRNA(GLN)
AMIDOTRANSFERASE
SUBUNIT A


(Thermus
thermophilus)
PF01425
(Amidase)
5 LEU E 106
GLY E 143
GLY E 144
ALA E  64
GLY E  79
None
0.96A 4n09D-3kfuE:
undetectable
4n09D-3kfuE:
22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kzh PROBABLE SUGAR
KINASE


(Clostridium
perfringens)
PF00294
(PfkB)
5 GLY A  42
GLY A  43
ASN A  47
GLY A 254
ASP A 257
None
0.37A 4n09D-3kzhA:
28.1
4n09D-3kzhA:
24.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l44 GLUTAMATE-1-SEMIALDE
HYDE 2,1-AMINOMUTASE
1


(Bacillus
anthracis)
PF00202
(Aminotran_3)
5 GLY A 273
GLY A 313
ALA A  79
ASN A 306
GLY A 305
LLP  A 270 ( 4.0A)
None
None
None
None
0.81A 4n09D-3l44A:
undetectable
4n09D-3l44A:
22.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3loo ANOPHELES GAMBIAE
ADENOSINE KINASE


(Anopheles
gambiae)
PF00294
(PfkB)
11 ASN A  14
ASP A  18
LEU A  40
GLY A  63
GLY A  64
ASN A  68
CYH A 122
ALA A 135
PHE A 168
GLY A 297
ASP A 300
B4P  A 349 ( 4.0A)
B4P  A 349 (-2.8A)
None
B4P  A 349 ( 3.8A)
B4P  A 349 (-3.5A)
B4P  A 349 (-3.6A)
B4P  A 349 (-3.6A)
B4P  A 349 (-3.4A)
B4P  A 349 (-3.4A)
B4P  A 349 (-2.9A)
B4P  A 349 (-3.4A)
0.55A 4n09D-3looA:
47.9
4n09D-3looA:
36.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3loo ANOPHELES GAMBIAE
ADENOSINE KINASE


(Anopheles
gambiae)
PF00294
(PfkB)
10 ASN A  14
LEU A  40
GLY A  64
ASN A  68
CYH A 122
ALA A 135
PHE A 168
ASN A 296
GLY A 297
ASP A 300
B4P  A 349 ( 4.0A)
None
B4P  A 349 (-3.5A)
B4P  A 349 (-3.6A)
B4P  A 349 (-3.6A)
B4P  A 349 (-3.4A)
B4P  A 349 (-3.4A)
B4P  A 349 (-3.6A)
B4P  A 349 (-2.9A)
B4P  A 349 (-3.4A)
0.91A 4n09D-3looA:
47.9
4n09D-3looA:
36.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3loo ANOPHELES GAMBIAE
ADENOSINE KINASE


(Anopheles
gambiae)
PF00294
(PfkB)
7 ASN A  14
LEU A  40
GLY A  64
ASN A  68
PHE A 168
GLY A 299
ASP A 300
B4P  A 349 ( 4.0A)
None
B4P  A 349 (-3.5A)
B4P  A 349 (-3.6A)
B4P  A 349 (-3.4A)
B4P  A 349 (-3.3A)
B4P  A 349 (-3.4A)
1.12A 4n09D-3looA:
47.9
4n09D-3looA:
36.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3loo ANOPHELES GAMBIAE
ADENOSINE KINASE


(Anopheles
gambiae)
PF00294
(PfkB)
6 GLY A  63
ASN A  68
CYH A 122
ALA A 135
GLY A 297
ASP A 300
B4P  A 349 ( 3.8A)
B4P  A 349 (-3.6A)
B4P  A 349 (-3.6A)
B4P  A 349 (-3.4A)
B4P  A 349 (-2.9A)
B4P  A 349 (-3.4A)
1.22A 4n09D-3looA:
47.9
4n09D-3looA:
36.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mdq EXOPOLYPHOSPHATASE

(Cytophaga
hutchinsonii)
PF02541
(Ppx-GppA)
5 LEU A  61
GLY A  40
ALA A  57
ASN A  89
GLY A  87
None
0.99A 4n09D-3mdqA:
undetectable
4n09D-3mdqA:
23.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ngm EXTRACELLULAR LIPASE

(Fusarium
graminearum)
PF01764
(Lipase_3)
5 LEU A 157
GLY A  63
GLY A  64
ALA A 153
GLY A  19
None
0.99A 4n09D-3ngmA:
undetectable
4n09D-3ngmA:
19.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3noq THIJ/PFPI FAMILY
PROTEIN


(Pseudomonas
fluorescens)
PF01965
(DJ-1_PfpI)
5 GLY A 150
GLY A 151
ALA A 123
GLY A  70
ASP A  17
None
None
NHE  A 501 ( 4.4A)
NHE  A 501 ( 4.7A)
EDO  A 604 ( 4.6A)
0.84A 4n09D-3noqA:
4.6
4n09D-3noqA:
22.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3otx ADENOSINE KINASE,
PUTATIVE


(Trypanosoma
brucei)
PF00294
(PfkB)
10 ASN A  13
ASP A  17
LEU A  39
GLY A  62
GLY A  63
ASN A  67
CYH A 123
ALA A 136
PHE A 169
ASP A 299
AP5  A 346 (-4.1A)
AP5  A 346 (-2.8A)
None
AP5  A 346 (-3.6A)
AP5  A 346 (-3.5A)
AP5  A 346 (-3.4A)
AP5  A 346 (-3.7A)
AP5  A 346 (-3.5A)
AP5  A 346 (-3.4A)
AP5  A 346 ( 3.2A)
0.18A 4n09D-3otxA:
58.3
4n09D-3otxA:
99.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3otx ADENOSINE KINASE,
PUTATIVE


(Trypanosoma
brucei)
PF00294
(PfkB)
7 ASN A  13
LEU A  39
GLY A  63
ASN A  67
PHE A 169
GLY A 298
ASP A 299
AP5  A 346 (-4.1A)
None
AP5  A 346 (-3.5A)
AP5  A 346 (-3.4A)
AP5  A 346 (-3.4A)
AP5  A 346 (-3.2A)
AP5  A 346 ( 3.2A)
1.06A 4n09D-3otxA:
58.3
4n09D-3otxA:
99.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3otx ADENOSINE KINASE,
PUTATIVE


(Trypanosoma
brucei)
PF00294
(PfkB)
7 ASP A  17
LEU A  39
GLY A  62
GLY A  63
CYH A 123
ALA A 136
GLY A 296
AP5  A 346 (-2.8A)
None
AP5  A 346 (-3.6A)
AP5  A 346 (-3.5A)
AP5  A 346 (-3.7A)
AP5  A 346 (-3.5A)
AP5  A 346 (-3.2A)
0.64A 4n09D-3otxA:
58.3
4n09D-3otxA:
99.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pl2 SUGAR KINASE,
RIBOKINASE FAMILY


(Corynebacterium
glutamicum)
PF00294
(PfkB)
6 ASP A  19
GLY A  40
GLY A  41
ASN A  45
GLY A 261
ASP A 264
None
0.60A 4n09D-3pl2A:
30.9
4n09D-3pl2A:
26.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q1y LIN2199 PROTEIN

(Listeria
innocua)
PF00294
(PfkB)
7 ASN A   8
ASP A  12
GLY A  37
GLY A  38
CYH A  92
GLY A 248
ASP A 251
None
0.98A 4n09D-3q1yA:
26.1
4n09D-3q1yA:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ry7 RIBOKINASE

(Staphylococcus
aureus)
PF00294
(PfkB)
5 ASP A  14
GLY A  40
GLY A  41
ASN A  45
ASP A 254
GOL  A 401 (-3.1A)
GOL  A 401 ( 3.7A)
GOL  A 401 (-3.8A)
GOL  A 401 (-3.9A)
None
0.51A 4n09D-3ry7A:
29.2
4n09D-3ry7A:
25.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3shw TIGHT JUNCTION
PROTEIN ZO-1


(Homo sapiens)
PF00595
(PDZ)
PF00625
(Guanylate_kin)
PF07653
(SH3_2)
5 ASP A 517
LEU A 487
GLY A 516
GLY A 439
ALA A 483
None
0.97A 4n09D-3shwA:
undetectable
4n09D-3shwA:
21.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tsw TIGHT JUNCTION
PROTEIN ZO-1


(Homo sapiens)
PF00595
(PDZ)
PF00625
(Guanylate_kin)
PF07653
(SH3_2)
5 ASP A 517
LEU A 487
GLY A 516
GLY A 439
ALA A 483
None
0.99A 4n09D-3tswA:
undetectable
4n09D-3tswA:
25.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ubo ADENOSINE KINASE

(Sinorhizobium
meliloti)
PF00294
(PfkB)
8 ASN A  11
ASP A  15
LEU A  37
GLY A  58
GLY A  59
ASN A  63
GLY A 275
ASP A 278
ADN  A 353 (-3.7A)
ADN  A 353 (-2.8A)
None
ADN  A 353 (-3.3A)
ADN  A 353 (-3.2A)
ADN  A 353 (-3.4A)
ADN  A 353 (-3.7A)
ADN  A 353 (-3.3A)
0.65A 4n09D-3uboA:
39.5
4n09D-3uboA:
29.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3uqe 6-PHOSPHOFRUCTOKINAS
E ISOZYME 2


(Escherichia
coli)
PF00294
(PfkB)
5 ASP A  14
GLY A  38
GLY A  39
ASN A  43
ASP A 256
None
0.76A 4n09D-3uqeA:
26.4
4n09D-3uqeA:
24.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3uqe 6-PHOSPHOFRUCTOKINAS
E ISOZYME 2


(Escherichia
coli)
PF00294
(PfkB)
5 GLY A  38
GLY A  39
ASN A  43
GLY A 253
ASP A 256
None
None
None
ATP  A 401 ( 4.1A)
None
0.53A 4n09D-3uqeA:
26.4
4n09D-3uqeA:
24.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3vas PUTATIVE ADENOSINE
KINASE


(Schistosoma
mansoni)
PF00294
(PfkB)
10 ASN A  14
ASP A  18
LEU A  40
GLY A  63
GLY A  64
ASN A  68
PHE A 169
ASN A 298
GLY A 299
ASP A 302
ADN  A 401 ( 4.0A)
ADN  A 401 (-2.7A)
None
ADN  A 401 ( 3.8A)
ADN  A 401 (-3.7A)
ADN  A 401 (-3.7A)
ADN  A 401 (-3.7A)
ADN  A 401 (-3.7A)
ADN  A 401 ( 3.8A)
ADN  A 401 (-2.9A)
0.54A 4n09D-3vasA:
47.4
4n09D-3vasA:
30.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3vas PUTATIVE ADENOSINE
KINASE


(Schistosoma
mansoni)
PF00294
(PfkB)
6 ASP A  18
LEU A 138
PHE A 169
ASN A 298
GLY A 299
ASP A 302
ADN  A 401 (-2.7A)
ADN  A 401 (-4.9A)
ADN  A 401 (-3.7A)
ADN  A 401 (-3.7A)
ADN  A 401 ( 3.8A)
ADN  A 401 (-2.9A)
1.46A 4n09D-3vasA:
47.4
4n09D-3vasA:
30.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b98 BETA-ALANINE--PYRUVA
TE TRANSAMINASE


(Pseudomonas
aeruginosa)
PF00202
(Aminotran_3)
5 LEU A 186
GLY A 416
GLY A 417
ASN A 169
GLY A 168
None
1.00A 4n09D-4b98A:
3.0
4n09D-4b98A:
22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4e3a SUGAR KINASE PROTEIN

(Rhizobium etli)
PF00294
(PfkB)
8 ASN A   9
ASP A  13
LEU A  35
GLY A  56
GLY A  57
ASN A  61
GLY A 273
ASP A 276
ADN  A 500 (-3.8A)
ADN  A 500 (-2.7A)
None
ADN  A 500 (-3.5A)
ADN  A 500 (-3.7A)
ADN  A 500 (-3.5A)
ADN  A 500 (-3.9A)
ADN  A 500 (-2.8A)
0.55A 4n09D-4e3aA:
40.8
4n09D-4e3aA:
25.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4e3a SUGAR KINASE PROTEIN

(Rhizobium etli)
PF00294
(PfkB)
6 ASN A   9
LEU A  35
GLY A  57
ASN A  61
GLY A 275
ASP A 276
ADN  A 500 (-3.8A)
None
ADN  A 500 (-3.7A)
ADN  A 500 (-3.5A)
None
ADN  A 500 (-2.8A)
1.20A 4n09D-4e3aA:
40.8
4n09D-4e3aA:
25.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4e84 D-BETA-D-HEPTOSE
7-PHOSPHATE KINASE


(Burkholderia
cenocepacia)
PF00294
(PfkB)
5 ASP A  29
GLY A  58
GLY A  59
GLY A 267
ASP A 270
M7B  A 502 (-2.9A)
M7B  A 502 (-3.4A)
M7B  A 502 (-3.6A)
M7B  A 502 (-3.7A)
M7B  A 502 (-3.1A)
0.94A 4n09D-4e84A:
26.6
4n09D-4e84A:
23.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4emd 4-DIPHOSPHOCYTIDYL-2
-C-METHYL-D-ERYTHRIT
OL KINASE


(Mycobacteroides
abscessus)
PF00288
(GHMP_kinases_N)
PF08544
(GHMP_kinases_C)
5 ASP A 117
GLY A 114
GLY A 113
ALA A  49
GLY A  68
None
SO4  A 402 (-3.4A)
SO4  A 402 (-3.8A)
None
None
0.97A 4n09D-4emdA:
undetectable
4n09D-4emdA:
24.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gm6 PFKB FAMILY
CARBOHYDRATE KINASE


(Listeria grayi)
PF00294
(PfkB)
6 LEU A 172
GLY A  33
GLY A  34
ASN A  38
GLY A 267
ASP A 270
None
GOL  A 401 ( 4.1A)
GOL  A 401 (-3.7A)
GOL  A 401 (-4.4A)
GOL  A 401 ( 4.5A)
GOL  A 401 (-3.0A)
0.98A 4n09D-4gm6A:
29.3
4n09D-4gm6A:
21.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4h1s 5'-NUCLEOTIDASE

(Homo sapiens)
PF00149
(Metallophos)
PF02872
(5_nucleotid_C)
5 GLY A 393
GLY A 392
ASN A 390
GLY A 505
ASP A 506
None
0.83A 4n09D-4h1sA:
undetectable
4n09D-4h1sA:
21.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jb3 HALOACID
DEHALOGENASE-LIKE
HYDROLASE


(Bacteroides
thetaiotaomicron)
PF13419
(HAD_2)
5 ASP A 172
LEU A  37
GLY A  11
GLY A  10
ASN A 176
NA  A 301 (-2.8A)
None
NA  A 301 ( 4.0A)
NA  A 301 (-4.4A)
None
0.92A 4n09D-4jb3A:
2.9
4n09D-4jb3A:
21.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oh1 L-IDITOL
2-DEHYDROGENASE


([Clostridium]
scindens)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 LEU A 162
GLY A 182
GLY A 183
ALA A 161
GLY A  46
None
None
None
None
OCS  A  45 ( 2.4A)
0.97A 4n09D-4oh1A:
5.6
4n09D-4oh1A:
22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oon PENICILLIN-BINDING
PROTEIN 1A


(Pseudomonas
aeruginosa)
PF00905
(Transpeptidase)
PF00912
(Transgly)
PF17092
(PCB_OB)
5 LEU A 685
GLY A 709
GLY A 694
ALA A 684
GLY A 697
None
None
None
None
2U4  A 901 (-3.7A)
0.99A 4n09D-4oonA:
undetectable
4n09D-4oonA:
20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rlb CARBAPENEM-ASSOCIATE
D RESISTANCE PROTEIN


(Acinetobacter
baumannii)
no annotation 5 LEU A  35
GLY A 151
ALA A  45
PHE A 165
GLY A 218
None
1.00A 4n09D-4rlbA:
undetectable
4n09D-4rlbA:
19.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4uhm OMEGA AMINO
ACID-PYRUVATE
AMINOTRANSFERASE


(Pseudomonas sp.)
PF00202
(Aminotran_3)
5 LEU A 186
GLY A 416
GLY A 417
ASN A 169
GLY A 168
None
None
None
CL  A1459 (-3.2A)
None
0.96A 4n09D-4uhmA:
2.7
4n09D-4uhmA:
22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4uoz BETA-GALACTOSIDASE

(Bifidobacterium
animalis)
PF02449
(Glyco_hydro_42)
PF08532
(Glyco_hydro_42M)
PF08533
(Glyco_hydro_42C)
5 LEU A 140
GLY A 162
ALA A 139
ASN A 169
GLY A 166
None
0.87A 4n09D-4uozA:
4.2
4n09D-4uozA:
20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wjm RIBOKINASE:CARBOHYDR
ATE KINASE, PFKB


(Brucella
abortus)
PF00294
(PfkB)
6 ASP A  11
GLY A  29
GLY A  30
ASN A  34
GLY A 246
ASP A 249
None
None
None
None
ANP  A 401 (-3.3A)
ANP  A 401 ( 4.3A)
0.52A 4n09D-4wjmA:
29.9
4n09D-4wjmA:
26.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wjm RIBOKINASE:CARBOHYDR
ATE KINASE, PFKB


(Brucella
abortus)
PF00294
(PfkB)
5 GLY A  30
ASN A  34
ALA A  85
GLY A 246
ASP A 249
None
None
None
ANP  A 401 (-3.3A)
ANP  A 401 ( 4.3A)
0.99A 4n09D-4wjmA:
29.9
4n09D-4wjmA:
26.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wjm RIBOKINASE:CARBOHYDR
ATE KINASE, PFKB


(Brucella
abortus)
PF00294
(PfkB)
5 LEU A 162
GLY A  29
GLY A  30
ASN A  34
ASP A 249
None
None
None
None
ANP  A 401 ( 4.3A)
0.93A 4n09D-4wjmA:
29.9
4n09D-4wjmA:
26.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4x8f RIBOKINASE

(Vibrio cholerae)
PF00294
(PfkB)
5 ASP A  13
GLY A  38
GLY A  39
ASN A  43
ASP A 252
None
0.55A 4n09D-4x8fA:
29.7
4n09D-4x8fA:
24.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z42 UREASE SUBUNIT ALPHA
UREASE SUBUNIT BETA


(Yersinia
enterocolitica)
PF00449
(Urease_alpha)
PF00699
(Urease_beta)
PF01979
(Amidohydro_1)
6 ASN C 104
ASP C 109
LEU B 124
GLY C 110
ASN B  50
GLY C  40
None
1.48A 4n09D-4z42C:
2.4
4n09D-4z42C:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5az4 FLAGELLAR HOOK
SUBUNIT PROTEIN


(Campylobacter
jejuni)
PF07196
(Flagellin_IN)
PF07559
(FlaE)
6 LEU A 296
GLY A 343
GLY A 345
ASN A 340
ALA A 316
ASP A 347
None
1.49A 4n09D-5az4A:
undetectable
4n09D-5az4A:
18.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5c41 RIBOKINASE

(Homo sapiens)
PF00294
(PfkB)
6 ASP A  27
GLY A  52
GLY A  53
ASN A  57
GLY A 266
ASP A 269
None
None
None
None
ACP  A 401 ( 4.1A)
NA  A 403 ( 4.7A)
0.55A 4n09D-5c41A:
32.4
4n09D-5c41A:
25.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5da0 SULPHATE TRANSPORTER

(Deinococcus
geothermalis)
PF00916
(Sulfate_transp)
PF01740
(STAS)
5 LEU A  35
GLY A 298
GLY A  72
ALA A 305
GLY A  68
None
0.98A 4n09D-5da0A:
undetectable
4n09D-5da0A:
21.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ey7 FRUCTOKINASE

(Vibrio cholerae)
PF00294
(PfkB)
5 ASP A  30
GLY A  44
GLY A  45
ASN A  49
ASP A 266
None
0.45A 4n09D-5ey7A:
31.1
4n09D-5ey7A:
23.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ey7 FRUCTOKINASE

(Vibrio cholerae)
PF00294
(PfkB)
5 ASP A  30
GLY A  45
ASN A  49
GLY A 263
ASP A 266
None
0.82A 4n09D-5ey7A:
31.1
4n09D-5ey7A:
23.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h7w VENOM
5'-NUCLEOTIDASE


(Naja atra)
no annotation 5 GLY A 393
GLY A 392
ASN A 390
GLY A 506
ASP A 507
None
0.86A 4n09D-5h7wA:
undetectable
4n09D-5h7wA:
20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h8y SULFITE REDUCTASE
[FERREDOXIN],
CHLOROPLASTIC


(Zea mays)
PF01077
(NIR_SIR)
PF03460
(NIR_SIR_ferr)
5 LEU A 497
GLY A 543
CYH A 494
ALA A 496
GLY A 553
None
SF4  A 701 (-4.4A)
SF4  A 701 ( 2.2A)
SF4  A 701 ( 3.9A)
None
0.91A 4n09D-5h8yA:
undetectable
4n09D-5h8yA:
20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5iof SULPHATE TRANSPORTER

(Deinococcus
geothermalis)
PF00916
(Sulfate_transp)
5 LEU A  35
GLY A 298
GLY A  72
ALA A 305
GLY A  68
None
0.98A 4n09D-5iofA:
undetectable
4n09D-5iofA:
23.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kgn 2,3-BISPHOSPHOGLYCER
ATE-INDEPENDENT
PHOSPHOGLYCERATE
MUTASE


(Caenorhabditis
elegans)
PF01676
(Metalloenzyme)
PF06415
(iPGM_N)
5 ASP A 426
GLY A  38
GLY A 469
ALA A 484
GLY A  89
MN  A 604 (-2.2A)
None
None
None
None
0.90A 4n09D-5kgnA:
3.3
4n09D-5kgnA:
21.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kva CAFFEOYL-COA
O-METHYLTRANSFERASE


(Sorghum bicolor)
PF01596
(Methyltransf_3)
5 LEU A 115
GLY A 197
GLY A 198
ALA A  94
PHE A 173
None
1.00A 4n09D-5kvaA:
4.7
4n09D-5kvaA:
20.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5o0j ADP-DEPENDENT
GLUCOKINASE


(Pyrococcus
horikoshii)
no annotation 5 ASP A  37
GLY A 114
GLY A 115
ALA A 204
ASP A 443
GLC  A 503 (-2.7A)
GLC  A 503 (-3.5A)
GLC  A 503 (-3.7A)
None
GLC  A 503 (-2.6A)
0.79A 4n09D-5o0jA:
23.9
4n09D-5o0jA:
13.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5o0j ADP-DEPENDENT
GLUCOKINASE


(Pyrococcus
horikoshii)
no annotation 5 ASP A  37
LEU A  93
GLY A 114
GLY A 115
ALA A 204
GLC  A 503 (-2.7A)
None
GLC  A 503 (-3.5A)
GLC  A 503 (-3.7A)
None
0.59A 4n09D-5o0jA:
23.9
4n09D-5o0jA:
13.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5od2 BIFUNCTIONAL
ADP-SPECIFIC
GLUCOKINASE/PHOSPHOF
RUCTOKINASE


(Methanocaldococcus
jannaschii)
no annotation 5 ASP A  28
GLY A 106
GLY A 107
ALA A 201
ASP A 442
GLC  A 501 (-2.7A)
GLC  A 501 (-3.2A)
GLC  A 501 (-3.7A)
None
GLC  A 501 ( 2.6A)
0.61A 4n09D-5od2A:
22.2
4n09D-5od2A:
14.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5od2 BIFUNCTIONAL
ADP-SPECIFIC
GLUCOKINASE/PHOSPHOF
RUCTOKINASE


(Methanocaldococcus
jannaschii)
no annotation 5 ASP A  28
GLY A 107
ALA A 201
GLY A 439
ASP A 442
GLC  A 501 (-2.7A)
GLC  A 501 (-3.7A)
None
PO4  A 504 (-3.1A)
GLC  A 501 ( 2.6A)
0.90A 4n09D-5od2A:
22.2
4n09D-5od2A:
14.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vdn GLUTATHIONE
OXIDOREDUCTASE


(Yersinia pestis)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 GLY A  26
GLY A  25
ALA A 327
ASN A 314
GLY A 150
None
FAD  A 502 (-3.6A)
None
None
FAD  A 502 (-3.3A)
0.94A 4n09D-5vdnA:
3.4
4n09D-5vdnA:
22.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vdn GLUTATHIONE
OXIDOREDUCTASE


(Yersinia pestis)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 LEU A 344
GLY A  26
ALA A 327
ASN A 314
GLY A 150
None
None
None
None
FAD  A 502 (-3.3A)
0.99A 4n09D-5vdnA:
3.4
4n09D-5vdnA:
22.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x4j UNCHARACTERIZED
PROTEIN


(Pyrococcus
furiosus)
no annotation 5 GLY A 138
GLY A 136
ALA A  41
GLY A 164
ASP A 165
None
ZN  A 501 ( 4.8A)
None
None
ZN  A 501 (-2.3A)
0.96A 4n09D-5x4jA:
3.1
4n09D-5x4jA:
12.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xb6 UNCHARACTERIZED
PROTEIN YCJY


(Escherichia
coli)
no annotation 5 LEU A 199
GLY A  45
GLY A  44
ALA A 202
GLY A 119
None
0.99A 4n09D-5xb6A:
3.8
4n09D-5xb6A:
13.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cw5 RIBOKINASE

(Cryptococcus
neoformans)
no annotation 5 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 273
GOL  A 400 (-2.8A)
GOL  A 400 (-3.5A)
GOL  A 400 (-3.3A)
GOL  A 400 (-3.3A)
None
0.35A 4n09D-6cw5A:
31.7
4n09D-6cw5A:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cw5 RIBOKINASE

(Cryptococcus
neoformans)
no annotation 5 ASP A  16
GLY A  42
ASN A  46
GLY A 270
ASP A 273
GOL  A 400 (-2.8A)
GOL  A 400 (-3.3A)
GOL  A 400 (-3.3A)
None
None
0.67A 4n09D-6cw5A:
31.7
4n09D-6cw5A:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dcn DELTA 2 CRYSTALLIN

(Anas
platyrhynchos)
PF00206
(Lyase_1)
PF14698
(ASL_C2)
4 LEU A 182
SER A 177
LEU A 457
LEU A 141
None
1.29A 4n09D-1dcnA:
undetectable
4n09D-1dcnA:
23.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ej6 LAMBDA1

(Reovirus sp.)
no annotation 4 CYH B 925
LEU B 997
SER B 517
LEU B 987
None
1.33A 4n09D-1ej6B:
undetectable
4n09D-1ej6B:
15.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1f2r INHIBITOR OF
CASPASE-ACTIVATED
DNASE


(Mus musculus)
PF02017
(CIDE-N)
4 LEU I  42
SER I  44
LEU I  49
LEU I  61
None
1.30A 4n09D-1f2rI:
undetectable
4n09D-1f2rI:
14.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fuu YEAST INITIATION
FACTOR 4A


(Saccharomyces
cerevisiae)
PF00270
(DEAD)
4 CYH A 123
LEU A  93
LEU A 189
LEU A  95
None
1.04A 4n09D-1fuuA:
4.2
4n09D-1fuuA:
22.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gqp DOC1/APC10

(Saccharomyces
cerevisiae)
PF03256
(ANAPC10)
4 LEU A 156
SER A 126
LEU A 234
LEU A 247
None
1.26A 4n09D-1gqpA:
undetectable
4n09D-1gqpA:
20.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hkk CHITOTRIOSIDASE-1

(Homo sapiens)
PF00704
(Glyco_hydro_18)
4 LEU A 127
SER A 122
LEU A 162
LEU A  94
None
1.22A 4n09D-1hkkA:
3.6
4n09D-1hkkA:
22.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1i0a DELTA CRYSTALLIN I

(Meleagris
gallopavo)
PF00206
(Lyase_1)
PF14698
(ASL_C2)
4 LEU A 180
SER A 175
LEU A 455
LEU A 139
None
1.33A 4n09D-1i0aA:
undetectable
4n09D-1i0aA:
23.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jl5 OUTER PROTEIN YOPM

(Yersinia pestis)
PF12468
(TTSSLRR)
4 LEU A1109
SER A1115
LEU A1093
LEU A1106
None
1.19A 4n09D-1jl5A:
undetectable
4n09D-1jl5A:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jl5 OUTER PROTEIN YOPM

(Yersinia pestis)
PF12468
(TTSSLRR)
4 LEU A1136
SER A1139
LEU A1117
LEU A1126
None
1.25A 4n09D-1jl5A:
undetectable
4n09D-1jl5A:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jl5 OUTER PROTEIN YOPM

(Yersinia pestis)
PF12468
(TTSSLRR)
4 LEU A1213
SER A1219
LEU A1197
LEU A1210
None
1.27A 4n09D-1jl5A:
undetectable
4n09D-1jl5A:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1k1b B-CELL LYMPHOMA
3-ENCODED PROTEIN


(Homo sapiens)
PF00023
(Ank)
PF12796
(Ank_2)
4 LEU A 305
SER A 307
LEU A 316
LEU A 350
None
1.18A 4n09D-1k1bA:
undetectable
4n09D-1k1bA:
21.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ox4 IMIDAZOLE GLYCEROL
PHOSPHATE SYNTHASE
HISHF


(Saccharomyces
cerevisiae)
PF00117
(GATase)
PF00977
(His_biosynth)
4 LEU B 468
SER B 402
LEU B 454
LEU B 484
None
1.33A 4n09D-1ox4B:
2.3
4n09D-1ox4B:
21.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1pdz ENOLASE

(Homarus
gammarus)
PF00113
(Enolase_C)
PF03952
(Enolase_N)
4 LEU A 144
SER A 176
LEU A 412
LEU A 418
None
1.24A 4n09D-1pdzA:
undetectable
4n09D-1pdzA:
23.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qva INITIATION FACTOR 4A

(Saccharomyces
cerevisiae)
PF00270
(DEAD)
4 CYH A 123
LEU A  93
LEU A 189
LEU A  95
None
1.13A 4n09D-1qvaA:
4.0
4n09D-1qvaA:
20.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1sgj CITRATE LYASE, BETA
SUBUNIT


(Deinococcus
radiodurans)
PF03328
(HpcH_HpaI)
4 LEU A 190
SER A  10
LEU A   7
LEU A 125
None
0.95A 4n09D-1sgjA:
2.7
4n09D-1sgjA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1smt TRANSCRIPTIONAL
REPRESSOR SMTB


(Synechococcus
elongatus)
PF01022
(HTH_5)
4 LEU A  88
SER A  82
LEU A  51
LEU A  43
None
1.32A 4n09D-1smtA:
undetectable
4n09D-1smtA:
18.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wb0 CHITOTRIOSIDASE 1

(Homo sapiens)
PF00704
(Glyco_hydro_18)
4 LEU A 127
SER A 122
LEU A 162
LEU A  94
None
1.23A 4n09D-1wb0A:
2.4
4n09D-1wb0A:
24.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zkl HIGH-AFFINITY
CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 7A


(Homo sapiens)
PF00233
(PDEase_I)
4 LEU A 198
SER A 172
LEU A 177
LEU A 194
None
1.17A 4n09D-1zklA:
undetectable
4n09D-1zklA:
21.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2b7h HEMOGLOBIN ALPHA
CHAIN


(Cerdocyon thous)
PF00042
(Globin)
4 LEU A  76
SER A 133
LEU A  66
LEU A   2
None
HEM  A 200 ( 4.8A)
HEM  A 200 ( 4.6A)
None
0.91A 4n09D-2b7hA:
undetectable
4n09D-2b7hA:
19.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bex RIBONUCLEASE
INHIBITOR


(Homo sapiens)
PF13516
(LRR_6)
4 CYH A 304
LEU A 342
LEU A 374
LEU A 317
None
1.24A 4n09D-2bexA:
undetectable
4n09D-2bexA:
21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bnh RIBONUCLEASE
INHIBITOR


(Sus scrofa)
PF13516
(LRR_6)
4 CYH A 300
LEU A 338
LEU A 370
LEU A 313
None
1.21A 4n09D-2bnhA:
undetectable
4n09D-2bnhA:
21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dw6 BLL6730 PROTEIN

(Bradyrhizobium
japonicum)
PF13378
(MR_MLE_C)
4 LEU A 289
SER A 315
LEU A 306
LEU A 277
None
1.30A 4n09D-2dw6A:
undetectable
4n09D-2dw6A:
22.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2eig LECTIN

(Lotus
tetragonolobus)
PF00139
(Lectin_legB)
4 LEU A 192
SER A 167
LEU A 227
LEU A  86
None
1.25A 4n09D-2eigA:
undetectable
4n09D-2eigA:
19.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g4r MOLYBDOPTERIN
BIOSYNTHESIS MOG
PROTEIN


(Mycobacterium
tuberculosis)
PF00994
(MoCF_biosynth)
4 CYH A  24
LEU A 128
SER A 131
LEU A 139
None
1.32A 4n09D-2g4rA:
undetectable
4n09D-2g4rA:
19.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hes YDR267CP

(Saccharomyces
cerevisiae)
PF00400
(WD40)
4 LEU X  27
SER X  40
LEU X  10
LEU X 304
None
1.33A 4n09D-2hesX:
undetectable
4n09D-2hesX:
23.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2i3o GAMMA-GLUTAMYLTRANSF
ERASE RELATED
PROTEIN


(Thermoplasma
acidophilum)
PF01019
(G_glu_transpept)
4 LEU A 409
SER A 411
LEU A 439
LEU A 425
None
1.31A 4n09D-2i3oA:
undetectable
4n09D-2i3oA:
22.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ilx 2',3'-CYCLIC-NUCLEOT
IDE
3'-PHOSPHODIESTERASE


(Rattus
norvegicus)
PF05881
(CNPase)
4 LEU A  70
SER A  18
LEU A 104
LEU A 153
None
1.29A 4n09D-2ilxA:
undetectable
4n09D-2ilxA:
21.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p5x N-ACETYLSEROTONIN
O-METHYLTRANSFERASE-
LIKE PROTEIN


(Homo sapiens)
PF02545
(Maf)
4 CYH A 205
LEU A  33
LEU A  17
LEU A  10
None
1.16A 4n09D-2p5xA:
undetectable
4n09D-2p5xA:
21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pyf T-CELL RECEPTOR,
BETA CHAIN


(Homo sapiens)
PF07654
(C1-set)
PF07686
(V-set)
4 LEU B 108
SER B 106
LEU B  74
LEU B  11
None
1.25A 4n09D-2pyfB:
undetectable
4n09D-2pyfB:
20.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rt5 MSX2-INTERACTING
PROTEIN


(Homo sapiens)
PF07744
(SPOC)
4 LEU A3642
SER A3637
LEU A3647
LEU A3575
None
1.25A 4n09D-2rt5A:
undetectable
4n09D-2rt5A:
18.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2uuu ALKYLDIHYDROXYACETON
EPHOSPHATE SYNTHASE


(Dictyostelium
discoideum)
PF01565
(FAD_binding_4)
PF02913
(FAD-oxidase_C)
4 LEU A 143
SER A 191
LEU A 146
LEU A 101
None
1.33A 4n09D-2uuuA:
undetectable
4n09D-2uuuA:
21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wui TRANSCRIPTIONAL
REGULATOR


(Pseudomonas
aeruginosa)
PF00440
(TetR_N)
PF08361
(TetR_C_2)
4 LEU A 196
SER A 198
LEU A 166
LEU A  85
None
1.33A 4n09D-2wuiA:
undetectable
4n09D-2wuiA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xxs PROTEIN MXIG

(Shigella
flexneri)
PF09480
(PrgH)
4 CYH A  72
LEU A 100
SER A  86
LEU A  23
None
1.22A 4n09D-2xxsA:
undetectable
4n09D-2xxsA:
14.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zf3 HYPOTHETICAL PROTEIN
VIOE


(Chromobacterium
violaceum)
no annotation 4 CYH A  35
SER A  15
LEU A 158
LEU A 110
None
1.23A 4n09D-2zf3A:
undetectable
4n09D-2zf3A:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3e4b ALGK

(Pseudomonas
fluorescens)
no annotation 4 LEU A 223
SER A 218
LEU A 240
LEU A 199
None
1.21A 4n09D-3e4bA:
undetectable
4n09D-3e4bA:
21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3efb PROBABLE SOR-OPERON
REGULATOR


(Shigella
flexneri)
PF04198
(Sugar-bind)
4 LEU A 263
SER A 258
LEU A  15
LEU A 253
None
1.22A 4n09D-3efbA:
3.8
4n09D-3efbA:
23.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3evz METHYLTRANSFERASE

(Pyrococcus
furiosus)
PF05175
(MTS)
4 LEU A 202
SER A 239
LEU A 211
LEU A 187
None
1.25A 4n09D-3evzA:
4.8
4n09D-3evzA:
22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3g7k 3-METHYLITACONATE
ISOMERASE


(Eubacterium
barkeri)
PF04303
(PrpF)
4 LEU A  63
SER A  61
LEU A  39
LEU A  22
None
1.23A 4n09D-3g7kA:
undetectable
4n09D-3g7kA:
24.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hdj PROBABLE ORNITHINE
CYCLODEAMINASE


(Bordetella
pertussis)
PF02423
(OCD_Mu_crystall)
4 CYH A 165
LEU A 143
LEU A 147
LEU A 137
None
1.30A 4n09D-3hdjA:
4.6
4n09D-3hdjA:
23.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hsk ASPARTATE-SEMIALDEHY
DE DEHYDROGENASE


(Candida
albicans)
PF01118
(Semialdhyde_dh)
PF02774
(Semialdhyde_dhC)
4 LEU A 102
SER A  96
LEU A   9
LEU A  76
None
1.31A 4n09D-3hskA:
3.8
4n09D-3hskA:
22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ijf CYTIDINE DEAMINASE

(Mycobacterium
tuberculosis)
PF00383
(dCMP_cyt_deam_1)
4 CYH X  59
LEU X  96
LEU X 119
LEU X  76
None
1.33A 4n09D-3ijfX:
undetectable
4n09D-3ijfX:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jb9 U2 SMALL NUCLEAR
RIBONUCLEOPROTEIN A'


(Schizosaccharomyces
pombe)
PF01423
(LSM)
4 LEU j  92
SER j 118
LEU j  69
LEU j  56
None
1.05A 4n09D-3jb9j:
undetectable
4n09D-3jb9j:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kl9 GLUTAMYL
AMINOPEPTIDASE


(Streptococcus
pneumoniae)
PF05343
(Peptidase_M42)
4 LEU A 207
SER A 209
LEU A  62
LEU A 192
None
1.28A 4n09D-3kl9A:
2.4
4n09D-3kl9A:
23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lfk MARR LIKE PROTEIN,
TVG0766549


(Thermoplasma
volcanium)
no annotation 4 LEU A  89
SER A  91
LEU A  77
LEU A  39
None
1.16A 4n09D-3lfkA:
undetectable
4n09D-3lfkA:
17.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3loo ANOPHELES GAMBIAE
ADENOSINE KINASE


(Anopheles
gambiae)
PF00294
(PfkB)
4 LEU A  16
SER A  65
LEU A 133
LEU A 137
B4P  A 349 (-4.7A)
CL  A 351 ( 4.6A)
B4P  A 349 (-4.5A)
None
0.47A 4n09D-3looA:
47.9
4n09D-3looA:
36.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ly9 TRANSCRIPTIONAL
ACTIVATOR CADC


(Escherichia
coli)
no annotation 4 LEU A 307
SER A 311
LEU A 231
LEU A 326
None
1.26A 4n09D-3ly9A:
undetectable
4n09D-3ly9A:
21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mn8 LP15968P

(Drosophila
melanogaster)
PF00246
(Peptidase_M14)
PF13620
(CarboxypepD_reg)
4 CYH A 299
SER A 213
LEU A 332
LEU A 377
None
1.27A 4n09D-3mn8A:
2.4
4n09D-3mn8A:
22.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mn8 LP15968P

(Drosophila
melanogaster)
PF00246
(Peptidase_M14)
PF13620
(CarboxypepD_reg)
4 LEU A 251
SER A 213
LEU A 332
LEU A 377
None
1.13A 4n09D-3mn8A:
2.4
4n09D-3mn8A:
22.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nwn KINESIN-LIKE PROTEIN
KIF9


(Homo sapiens)
PF00225
(Kinesin)
4 CYH A 295
LEU A 275
SER A 271
LEU A 301
None
1.14A 4n09D-3nwnA:
undetectable
4n09D-3nwnA:
20.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3otx ADENOSINE KINASE,
PUTATIVE


(Trypanosoma
brucei)
PF00294
(PfkB)
5 CYH A  12
LEU A  15
SER A  64
LEU A 134
LEU A 138
AP5  A 346 (-3.6A)
AP5  A 346 (-4.4A)
NA  A 347 (-4.8A)
AP5  A 346 ( 4.4A)
None
0.26A 4n09D-3otxA:
58.3
4n09D-3otxA:
99.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s30 HYPOTHETICAL
GLYCOSIDE HYDROLASE


(Bacteroides
vulgatus)
PF13201
(PCMD)
4 LEU A 150
SER A 163
LEU A 160
LEU A 195
None
1.25A 4n09D-3s30A:
undetectable
4n09D-3s30A:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s5k FALCILYSIN

(Plasmodium
falciparum)
PF00675
(Peptidase_M16)
PF05193
(Peptidase_M16_C)
PF08367
(M16C_assoc)
4 LEU A1015
SER A1060
LEU A1022
LEU A1156
None
1.19A 4n09D-3s5kA:
undetectable
4n09D-3s5kA:
13.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tsr RIBONUCLEASE
INHIBITOR


(Mus musculus)
PF13516
(LRR_6)
4 CYH E 300
LEU E 338
LEU E 370
LEU E 313
None
1.19A 4n09D-3tsrE:
undetectable
4n09D-3tsrE:
21.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4d3c SFN68 FAB

(Oryctolagus
cuniculus)
PF07654
(C1-set)
PF07686
(V-set)
4 LEU L   2
SER L  28
LEU L  32
LEU L   4
None
1.12A 4n09D-4d3cL:
undetectable
4n09D-4d3cL:
19.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ewj ENOLASE 2

(Streptococcus
suis)
PF00113
(Enolase_C)
PF03952
(Enolase_N)
4 LEU A 142
SER A 174
LEU A 412
LEU A 418
None
1.27A 4n09D-4ewjA:
undetectable
4n09D-4ewjA:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ft2 DNA
(CYTOSINE-5)-METHYLT
RANSFERASE 1


(Zea mays)
PF00145
(DNA_methylase)
PF00385
(Chromo)
PF01426
(BAH)
4 CYH A 512
SER A 354
LEU A 359
LEU A 865
None
0.86A 4n09D-4ft2A:
5.6
4n09D-4ft2A:
19.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4k37 ANAEROBIC
SULFATASE-MATURATING
ENZYME


(Clostridium
perfringens)
PF04055
(Radical_SAM)
PF13186
(SPASM)
PF13353
(Fer4_12)
4 LEU A 112
SER A 107
LEU A 152
LEU A  97
None
1.04A 4n09D-4k37A:
2.5
4n09D-4k37A:
21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kpp PUTATIVE
UNCHARACTERIZED
PROTEIN


(Archaeoglobus
fulgidus)
PF01699
(Na_Ca_ex)
4 LEU A 145
SER A 280
LEU A 140
LEU A 331
None
1.29A 4n09D-4kppA:
undetectable
4n09D-4kppA:
21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lry PTS-DEPENDENT
DIHYDROXYACETONE
KINASE,
DIHYDROXYACETONE-BIN
DING SUBUNIT DHAK


(Escherichia
coli)
PF02733
(Dak1)
4 CYH A 304
LEU A 272
LEU A 333
LEU A 242
None
1.10A 4n09D-4lryA:
2.8
4n09D-4lryA:
21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4m0m PUTATIVE
UNCHARACTERIZED
PROTEIN


(Legionella
pneumophila)
no annotation 4 LEU A 438
SER A 440
LEU A 464
LEU A 482
None
1.31A 4n09D-4m0mA:
4.9
4n09D-4m0mA:
19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mdr AP-4 COMPLEX SUBUNIT
MU-1


(Homo sapiens)
PF00928
(Adap_comp_sub)
4 LEU A 315
SER A 301
LEU A 377
LEU A 334
None
1.11A 4n09D-4mdrA:
undetectable
4n09D-4mdrA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mhp GLUTAMINYL CYCLASE,
PUTATIVE


(Ixodes
scapularis)
PF04389
(Peptidase_M28)
4 LEU A 163
SER A 158
LEU A  88
LEU A 175
None
1.07A 4n09D-4mhpA:
undetectable
4n09D-4mhpA:
22.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nzk UNCHARACTERIZED
PROTEIN


([Eubacterium]
siraeum)
PF14286
(DHHW)
4 CYH A 209
LEU A 314
SER A 332
LEU A 361
None
1.27A 4n09D-4nzkA:
2.5
4n09D-4nzkA:
21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4peq RIBONUCLEASE/ANGIOGE
NIN INHIBITOR 1


(Bos taurus)
PF13516
(LRR_6)
4 CYH B 300
LEU B 338
LEU B 370
LEU B 313
None
1.26A 4n09D-4peqB:
undetectable
4n09D-4peqB:
21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4peq RIBONUCLEASE/ANGIOGE
NIN INHIBITOR 1


(Bos taurus)
PF13516
(LRR_6)
4 CYH B 324
LEU B 343
LEU B 313
LEU B 356
None
1.26A 4n09D-4peqB:
undetectable
4n09D-4peqB:
21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4peq RIBONUCLEASE/ANGIOGE
NIN INHIBITOR 1


(Bos taurus)
PF13516
(LRR_6)
4 CYH B 357
LEU B 395
LEU B 427
LEU B 370
None
1.26A 4n09D-4peqB:
undetectable
4n09D-4peqB:
21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4per RIBONUCLEASE
INHIBITOR


(Gallus gallus)
PF13516
(LRR_6)
4 CYH A 300
LEU A 338
LEU A 370
LEU A 313
None
1.30A 4n09D-4perA:
undetectable
4n09D-4perA:
21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4psp ALPHA-FUCOSIDASE
GH29


(Fusarium
graminearum)
PF01120
(Alpha_L_fucos)
PF16757
(Fucosidase_C)
4 LEU A 198
SER A 190
LEU A 195
LEU A 206
None
1.04A 4n09D-4pspA:
2.9
4n09D-4pspA:
20.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pxh PEPTIDE SYNTHETASE

(Streptomyces
sp. Acta 2897)
PF00550
(PP-binding)
4 LEU B  60
SER B  50
LEU B  62
LEU B  74
None
1.07A 4n09D-4pxhB:
undetectable
4n09D-4pxhB:
13.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qdg PUTATIVE ADHESIN

(Bacteroides
thetaiotaomicron)
PF08842
(Mfa2)
4 LEU A  97
SER A  44
LEU A 161
LEU A  68
None
1.22A 4n09D-4qdgA:
undetectable
4n09D-4qdgA:
21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qdn FLAGELLAR PROTEIN
FLGJ [PEPTIDOGLYCAN
HYDROLASE]


(Thermotoga
maritima)
PF01832
(Glucosaminidase)
4 LEU A  27
SER A  12
LEU A  46
LEU A  89
None
1.05A 4n09D-4qdnA:
undetectable
4n09D-4qdnA:
18.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qfv ANK-N5C-281

(synthetic
construct)
PF00023
(Ank)
PF12796
(Ank_2)
PF13637
(Ank_4)
4 LEU A 174
SER A 176
LEU A 185
LEU A 222
None
1.24A 4n09D-4qfvA:
undetectable
4n09D-4qfvA:
19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tlv ADP-RIBOSYLATING
TOXIN CARDS


(Mycoplasma
pneumoniae)
PF02917
(Pertussis_S1)
4 LEU A  38
SER A 225
LEU A 123
LEU A 260
None
1.27A 4n09D-4tlvA:
undetectable
4n09D-4tlvA:
19.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4w8j PESTICIDAL CRYSTAL
PROTEIN CRY1AC


(Bacillus
thuringiensis)
PF00555
(Endotoxin_M)
PF03944
(Endotoxin_C)
PF03945
(Endotoxin_N)
4 LEU A 656
SER A 669
LEU A 662
LEU A 618
None
1.09A 4n09D-4w8jA:
undetectable
4n09D-4w8jA:
14.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yac C
ALPHA-DEHYDROGENASE


(Sphingobium sp.
SYK-6)
PF00106
(adh_short)
4 LEU A 185
SER A 144
LEU A 250
LEU A 234
None
0.85A 4n09D-4yacA:
7.8
4n09D-4yacA:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z17 ENOLASE

(Chloroflexus
aurantiacus)
PF00113
(Enolase_C)
PF03952
(Enolase_N)
4 LEU A 143
SER A 175
LEU A 406
LEU A 412
None
1.22A 4n09D-4z17A:
undetectable
4n09D-4z17A:
21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z61 PHYTOSULFOKINE
RECEPTOR 1


(Daucus carota)
PF00560
(LRR_1)
PF13855
(LRR_8)
4 LEU A 451
SER A 446
LEU A 469
LEU A 430
None
1.24A 4n09D-4z61A:
undetectable
4n09D-4z61A:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zke SUPERKILLER PROTEIN
7


(Saccharomyces
cerevisiae)
PF00009
(GTP_EFTU)
4 LEU A 687
SER A 697
LEU A 704
LEU A 674
LEU  A 687 ( 0.6A)
SER  A 697 ( 0.0A)
LEU  A 704 ( 0.6A)
LEU  A 674 ( 0.6A)
1.10A 4n09D-4zkeA:
3.7
4n09D-4zkeA:
20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zoq INTRACELLULAR SERINE
PROTEASE


(Bacillus
licheniformis)
PF00082
(Peptidase_S8)
4 LEU I 345
SER I 370
LEU I 377
LEU I 330
None
1.02A 4n09D-4zoqI:
4.9
4n09D-4zoqI:
20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5by7 3-OXOACYL-ACP
SYNTHASE III


(Verrucosispora
maris)
PF08541
(ACP_syn_III_C)
PF08545
(ACP_syn_III)
4 LEU A 167
SER A -10
LEU A 127
LEU A 111
None
1.13A 4n09D-5by7A:
undetectable
4n09D-5by7A:
23.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fyq NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-2


(Homo sapiens)
PF02146
(SIR2)
4 CYH A 148
LEU A 258
LEU A 284
LEU A 331
None
1.27A 4n09D-5fyqA:
5.8
4n09D-5fyqA:
22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hsg PUTATIVE ABC
TRANSPORTER,
NUCLEOTIDE
BINDING/ATPASE
PROTEIN


(Klebsiella
pneumoniae)
PF13407
(Peripla_BP_4)
4 LEU A 315
SER A 311
LEU A 252
LEU A  49
None
1.03A 4n09D-5hsgA:
5.5
4n09D-5hsgA:
24.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j04 ENOLASE

(Synechococcus
elongatus)
PF00113
(Enolase_C)
PF03952
(Enolase_N)
4 LEU A 146
SER A 178
LEU A 407
LEU A 413
None
1.32A 4n09D-5j04A:
undetectable
4n09D-5j04A:
23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jpw DYNEIN LIGHT CHAIN
TCTEX-TYPE
1,CYTOPLASMIC DYNEIN
1 INTERMEDIATE CHAIN
2


(Homo sapiens)
PF03645
(Tctex-1)
PF11540
(Dynein_IC2)
4 CYH A  95
LEU A  56
SER A  20
LEU A  53
None
1.19A 4n09D-5jpwA:
undetectable
4n09D-5jpwA:
16.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ks8 PYRUVATE CARBOXYLASE
SUBUNIT BETA


(Methylobacillus
flagellatus)
PF00364
(Biotin_lipoyl)
PF00682
(HMGL-like)
PF02436
(PYC_OADA)
4 LEU C  73
SER C  33
LEU C  29
LEU C  43
None
1.27A 4n09D-5ks8C:
2.1
4n09D-5ks8C:
19.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n2s SOLUBLE CYTOCHROME
B562,ADENOSINE
RECEPTOR A1


(Escherichia
coli;
Homo sapiens)
PF00001
(7tm_1)
PF07361
(Cytochrom_B562)
4 LEU A1156
SER A1386
LEU A1195
LEU A1203
None
1.17A 4n09D-5n2sA:
undetectable
4n09D-5n2sA:
21.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5opq 3,6-ANHYDRO-D-GALACT
OSIDASE


(Zobellia
galactanivorans)
no annotation 4 LEU A 418
SER A 420
LEU A 512
LEU A 333
None
0.79A 4n09D-5opqA:
undetectable
4n09D-5opqA:
12.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5oqr CONDENSIN COMPLEX
SUBUNIT 3


(Schizosaccharomyces
pombe)
no annotation 4 LEU A 385
SER A 387
LEU A 408
LEU A 422
None
0.95A 4n09D-5oqrA:
undetectable
4n09D-5oqrA:
17.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tc1 MATURATION PROTEIN

(Escherichia
virus MS2)
PF03863
(Phage_mat-A)
4 LEU M  65
SER M 100
LEU M 104
LEU M 111
None
1.18A 4n09D-5tc1M:
undetectable
4n09D-5tc1M:
21.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u30 CRISPR-ASSOCIATED
ENDONUCLEASE C2C1


(Alicyclobacillus
acidoterrestris)
no annotation 4 LEU A 847
SER A 568
LEU A 844
LEU A 879
None
1.22A 4n09D-5u30A:
undetectable
4n09D-5u30A:
15.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ul4 OXSB PROTEIN

(Bacillus
megaterium)
PF02310
(B12-binding)
4 LEU A 541
SER A 594
LEU A 486
LEU A 640
EDO  A 814 (-4.8A)
None
None
None
1.27A 4n09D-5ul4A:
5.8
4n09D-5ul4A:
19.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ux5 BIFUNCTIONAL PROTEIN
PROLINE UTILIZATION
A (PUTA)


(Corynebacterium
freiburgense)
PF00171
(Aldedh)
PF01619
(Pro_dh)
4 LEU A 169
SER A 190
LEU A 207
LEU A 214
None
1.09A 4n09D-5ux5A:
undetectable
4n09D-5ux5A:
15.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5v7i SERINE
HYDROXYMETHYLTRANSFE
RASE, MITOCHONDRIAL


(Homo sapiens)
no annotation 4 LEU A 164
SER A 226
LEU A 166
LEU A 197
None
LLP  A 280 (-3.4A)
8Z1  A 601 (-4.7A)
None
1.14A 4n09D-5v7iA:
4.7
4n09D-5v7iA:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wde KINESIN-LIKE PROTEIN
KIFC3


(Homo sapiens)
PF00225
(Kinesin)
4 CYH A 523
SER A 732
LEU A 606
LEU A 725
None
UNX  A 932 ( 2.7A)
None
None
1.24A 4n09D-5wdeA:
undetectable
4n09D-5wdeA:
20.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x41 COBALT ABC
TRANSPORTER
ATP-BINDING PROTEIN


(Rhodobacter
capsulatus)
PF00005
(ABC_tran)
4 LEU A  37
SER A 196
LEU A 202
LEU A 239
None
0.84A 4n09D-5x41A:
undetectable
4n09D-5x41A:
23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c54 NUCLEOPROTEIN

(Zaire
ebolavirus)
no annotation 4 LEU A  74
SER A  72
LEU A 209
LEU A 203
None
0.96A 4n09D-6c54A:
undetectable
4n09D-6c54A:
14.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ccz SERINE
HYDROXYMETHYLTRANSFE
RASE


(Medicago
truncatula)
no annotation 4 LEU A 202
SER A 264
LEU A 204
LEU A 235
None
ACT  A 612 (-2.7A)
None
None
1.08A 4n09D-6cczA:
undetectable
4n09D-6cczA:
12.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cfw MONOVALENT CATION/H+
ANTIPORTER SUBUNIT B
MONOVALENT CATION/H+
ANTIPORTER SUBUNIT F
MONOVALENT CATION/H+
ANTIPORTER SUBUNIT G


(Pyrococcus
furiosus)
no annotation 4 LEU B  66
SER B  68
LEU C  83
LEU F  16
None
1.03A 4n09D-6cfwB:
undetectable
4n09D-6cfwB:
14.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ez8 HUNTINGTIN

(Homo sapiens)
no annotation 4 LEU A1267
SER A1271
LEU A1141
LEU A1293
None
1.24A 4n09D-6ez8A:
undetectable
4n09D-6ez8A:
8.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6g2j NADH-UBIQUINONE
OXIDOREDUCTASE CHAIN
4


(Mus musculus)
no annotation 4 LEU M 106
SER M 101
LEU M  73
LEU M 235
None
3PE  M 505 ( 3.8A)
None
None
0.88A 4n09D-6g2jM:
undetectable
4n09D-6g2jM:
11.90